newsfilter
← Latest News
GlobeNewswire·

VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines

ZURICH, SWITZERLAND – July 6, 2026 -- VERAXA Biotech AG (NASDAQ:VRXA, "VERAXA")), an emerging leader in designing novel cancer therapies, today provided a company and pipeline update. "In the first six